Common Contracts
3 similar Underwriting Agreement contracts by Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences Los Angeles, California 90071Underwriting Agreement • October 25th, 2024 • Oaktree Acquisition Corp. III Life Sciences • Blank checks
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Oaktree Acquisition Corp. III Life Sciences, a Cayman Islands exempted company (the “Company”) and Jefferies LLC, Citigroup Global Markets Inc. and UBS Securities LLC, as representatives (the “Representatives”) of the underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of up to 20,125,000 units of the Company (including 2,625,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units pursuant to the terms of the Underwriting Agreement), each such unit comprised of one Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”) and one-fifth of a redeemable warrant to purchase one Ordinary Share as provided for by the warrant agreement (the “Warrant Agreement”) to be entered into with Continental S
Oaktree Acquisition Corp. III Life Sciences Los Angeles, California 90071Underwriting Agreement • October 4th, 2024 • Oaktree Acquisition Corp. III Life Sciences • Blank checks
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Oaktree Acquisition Corp. III Life Sciences, a Cayman Islands exempted company (the “Company”) and Jefferies LLC, Citigroup Global Markets Inc. and UBS Securities LLC, as representatives (the “Representatives”) of the underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of up to 20,125,000 units of the Company (including 2,625,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units pursuant to the terms of the Underwriting Agreement), each such unit comprised of one Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”) and one-fifth of a redeemable warrant to purchase one Ordinary Share as provided for by the warrant agreement (the “Warrant Agreement”) to be entered into with Continental S
Oaktree Acquisition Corp. III Life Sciences Los Angeles, California 90071Underwriting Agreement • September 13th, 2024 • Oaktree Acquisition Corp. III Life Sciences • Blank checks
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Oaktree Acquisition Corp. III Life Sciences, a Cayman Islands exempted company (the “Company”) and Jefferies LLC, Citigroup Global Markets Inc. and UBS Securities LLC, as representatives (the “Representatives”) of the underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of up to 20,125,000 units of the Company (including 2,625,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units pursuant to the terms of the Underwriting Agreement), each such unit comprised of one Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”) and one-fifth of a redeemable warrant to purchase one Ordinary Share as provided for by the warrant agreement (the “Warrant Agreement”) to be entered into with Continental S
